BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 16504694)

  • 21. Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.
    Trappe R; Riess H; Babel N; Hummel M; Lehmkuhl H; Jonas S; Anagnostopoulos I; Papp-Vary M; Reinke P; Hetzer R; Dörken B; Oertel S
    Transplantation; 2007 Apr; 83(7):912-8. PubMed ID: 17460562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease.
    Rohr JC; Wagner HJ; Lauten M; Wacker HH; Jüttner E; Hanke C; Pohl M; Niemeyer CM
    Pediatr Transplant; 2008 Jun; 12(4):426-31. PubMed ID: 18466428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-transplant lymphoproliferative disorders after heart or kidney transplantation at a single centre: presentation and response to treatment.
    Aversa SM; Stragliotto S; Marino D; Calabrese F; Rigotti P; Marchini F; Gambino A; Feltrin G; Boso C; Canova F; Soldà C; Mazzarotto R; Burra P
    Acta Haematol; 2008; 120(1):36-46. PubMed ID: 18797163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Posttransplant Lymphoproliferative Disorder in Kidney and Liver Transplant Recipients: A Single-Center Experience.
    Wójciak M; Gozdowska J; Dęborska-Materkowska D; Perkowska-Ptasińska A; Kosieradzki M; Nazarewski S; Durlik M
    Transplant Proc; 2018 Sep; 50(7):2154-2158. PubMed ID: 30177129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thoracic presentations of posttransplant lymphoproliferative disorders.
    Halkos ME; Miller JI; Mann KP; Miller DL; Gal AA
    Chest; 2004 Dec; 126(6):2013-20. PubMed ID: 15596707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.
    Maecker B; Jack T; Zimmermann M; Abdul-Khaliq H; Burdelski M; Fuchs A; Hoyer P; Koepf S; Kraemer U; Laube GF; Müller-Wiefel DE; Netz H; Pohl M; Toenshoff B; Wagner HJ; Wallot M; Welte K; Melter M; Offner G; Klein C
    J Clin Oncol; 2007 Nov; 25(31):4902-8. PubMed ID: 17971586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus.
    Koch DG; Christiansen L; Lazarchick J; Stuart R; Willner IR; Reuben A
    Liver Transpl; 2007 Jun; 13(6):904-12. PubMed ID: 17539010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Paraneoplastic lymphadenopathy].
    Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
    Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term survival after post-transplant lymphoproliferative disease in children.
    Nathanson S; Debray D; Delarue A; Deschênes G
    Pediatr Nephrol; 2002 Aug; 17(8):668-72. PubMed ID: 12185479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posttransplant lymphoproliferative disorder: a pictorial review.
    Burney K; Bradley M; Buckley A; Lyburn I; Rye A; Hopkins R
    Australas Radiol; 2006 Oct; 50(5):412-8. PubMed ID: 16981935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B-cell posttransplant lymphoproliferative disorders in heart and/or lungs recipients: clinical and molecular-histogenetic study of 17 cases from a single institution.
    Lucioni M; Capello D; Riboni R; Ippoliti G; Campana C; Bandiera L; Arcaini L; Rossi D; Cerri M; Dionigi P; Lazzarino M; Magrini U; Viganò M; Gaidano G; Paulli M
    Transplantation; 2006 Oct; 82(8):1013-23. PubMed ID: 17060848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tonsil enlargement after liver transplantation in adults--reason enough for tonsillectomy? Two cases of tonsillar posttransplantation lymphoproliferative disease.
    Mucha K; Foroncewicz B; Niemczyk K; Ziarkiewicz-Wróblewska B; Stanisławek-Sut O; Zieniewicz K; Krawczyk M; Paczek L
    Liver Transpl; 2007 Jun; 13(6):918-23. PubMed ID: 17539016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete absence of KSHV/HHV-8 in posttransplant lymphoproliferative disorders: an immunohistochemical and molecular study of 52 cases.
    Chen W; Huang Q; Zuppan CW; Rowsell EH; Cao JD; Weiss LM; Wang J
    Am J Clin Pathol; 2009 May; 131(5):632-9. PubMed ID: 19369621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS; Tsodikov A; Cibrik DM; Ross CW; Kaminski MS; Blayney DW
    J Clin Oncol; 2009 Jul; 27(20):3354-62. PubMed ID: 19451438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary cutaneous giant cell plasmacytoma in an organ transplant recipient: a rare presentation of a posttransplant lymphoproliferative disorder.
    Wang E; Stoecker M
    Am J Dermatopathol; 2010 Jul; 32(5):479-85. PubMed ID: 20414094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients.
    Beynet DP; Wee SA; Horwitz SS; Kohler S; Horning S; Hoppe R; Kim YH
    Arch Dermatol; 2004 Sep; 140(9):1140-6. PubMed ID: 15381556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of fulminant post-transplant lymphoproliferative disorder and septicemia.
    Gouya G; Hartmann G; Faè P; Tauber M; Holzmüller H; Benzer W; Lang A; Schuster A; Drexel H; Offner FA
    Clin Transplant; 2006; 20(2):261-4. PubMed ID: 16640537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extramedullary plasmacytoma-like posttransplantation lymphoproliferative disorders: clinical and pathologic features.
    Richendollar BG; Hsi ED; Cook JR
    Am J Clin Pathol; 2009 Oct; 132(4):581-8. PubMed ID: 19762536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
    Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC
    Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful prolonged rituximab treatment for post-transplant lymphoproliferative disorder following living donor liver transplantation in a child.
    Hayashida M; Ogita K; Matsuura T; Takahashi Y; Nishimoto Y; Ohga S; Hara T; Soejima Y; Taketomi A; Maehara Y; Kohashi K; Tsuneyoshi M; Taguchi T
    Pediatr Transplant; 2007 Sep; 11(6):671-5. PubMed ID: 17663692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.